Dr Sarah Walsh s.walsh@rgu.ac.uk
Research Fellow
Protective effects of cannabidiol in combined chemotherapy induced cardiotoxicity
People Involved
Project Description
Doxorubicin, an anthracycline, is one of the most effective and commonly used drugs for the treatment of cancer. This anthracycline is used both alone and in combination with other chemotherapeutic agents such as taxanes e.g. paclitaxel. Despite its success as an anti-cancer agent, doxorubicin alone and in combination with paclitaxel, is one of the most toxic anthracyclines in clinical use and induces both acute (atrial and ventricular arrhythmias) and chronic (heart failure) cardiotoxic effects. At present the only preventative strategy available for doxorubicin induced cardiotoxicity (DIC) is to limit the amount of anthracycline administered, however clinical data suggests this approach is not entirely successful. Cannabidiol (CBD; derived from the cannabis plant) has been shown to exert numerous cytoprotective effects including antioxidant and anti-apoptotic effects. Recently, CBD has been shown to improve cardiovascular function in a rat model of DIC and prevent the development of paclitaxel-induced neuropathic pain in mice. However, it is unknown whether CBD can protect against anthracycline-taxane combined therapy induced cardiotoxicity and thus the proposed the project will investigate this.
| Status | Project Complete |
|---|---|
| Funder(s) | Medical Research Scotland |
| Value | £2,000.00 |
| Project Dates | Jul 8, 2019 - Sep 1, 2019 |
You might also like
sFRPs as a novel modulator of diastolic heart failure Oct 1, 2017 - Dec 31, 2021
Following a heart attack, or because of persistently high blood pressure the heart is damaged and has to work harder to circulate blood around the body. This condition is known as heart failure. In the UK alone, 500,000 people have heart failure re...
Read More about sFRPs as a novel modulator of diastolic heart failure.
Exploring the relationship between age-related zinc deficiency and obesity and the extent of myocardial damage following acute myocardial infarction Oct 1, 2018 - Jan 1, 2021
Zinc (Zn 2+) is a metal found in trace amounts in the body and plays an essential role in maintaining the healthy functioning of most organs, including the heart. The body does not store zinc in large quantities and so replenishment of Zn 2+ through...
Read More about Exploring the relationship between age-related zinc deficiency and obesity and the extent of myocardial damage following acute myocardial infarction.
Protective effects of cannabidiol in doxorubicin induced cardiotoxicity Oct 1, 2018 - Dec 31, 2019
A novel G protein-coupled receptor target for metabolic syndrome Sep 1, 2020 - Feb 28, 2022
Metabolic syndrome is the medical term for a group of risk factors that increase the likelihood of developing heart disease, diabetes, and stroke. The risk factors for metabolic syndrome include high blood pressure, high blood sugar (insulin resistan...
Read More about A novel G protein-coupled receptor target for metabolic syndrome.
Bioactivity of compounds derived from Amaryllicaea (Daffodil) Feb 1, 2021 - Jul 31, 2022
Heart Failure (HF) is a long-term complication of cardiovascular (high blood pressure and heart attack) and cardiovascular-related (obesity and metabolic syndrome) disorders and of drug-induced cardiotoxicity. HF is characterised by thickening (hype...
Read More about Bioactivity of compounds derived from Amaryllicaea (Daffodil).